Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 66158-96-1 | MDL No. : | MFCD03086171 |
Formula : | C9H10O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | ITMGMSZDAOAVNO-UHFFFAOYSA-N |
M.W : | 150.17 | Pubchem ID : | 2795428 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.33 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 41.75 |
TPSA : | 29.46 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.29 cm/s |
Log Po/w (iLOGP) : | 1.71 |
Log Po/w (XLOGP3) : | 1.31 |
Log Po/w (WLOGP) : | 0.98 |
Log Po/w (MLOGP) : | 1.14 |
Log Po/w (SILICOS-IT) : | 1.93 |
Consensus Log Po/w : | 1.41 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.93 |
Solubility : | 1.75 mg/ml ; 0.0116 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.53 |
Solubility : | 4.44 mg/ml ; 0.0296 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.27 |
Solubility : | 0.808 mg/ml ; 0.00538 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.33 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
77% | With 2,2,6,6-tetramethyl-piperidine-N-oxyl; sodium hypochlorite; sodium hydrogencarbonate; potassium bromide In tetrahydrofuran; water for 3 h; | To a stirred solution of 6 (119 mg, 0.792 mmol) in tetrahydrofuran (THF) and saturated NaHCO3 solution (1:1) (12 mL) was added TEMPO (2,2,6,6,-tetramethylpiperidine-1-oxyl) (24.0 mg, 0.154 mmol), ΚBr (24.0 mg, 0.202 mmol), and NaOCl aq (2.38 mL). After stirring for 3h, the reaction mixture was diluted by diethyl ether (20 mL) and acidified with 1N HCl to pH 2. The mixture was extracted with EtOAc (3 × 20 mL) and the combined extracts were dried over anhydrous Na2SO4. After evaporation, the product was dried in vacuo to afford the desired 2,3-dihydrobenzofuran-2-carboxylic acid (7) (100 mg, 77percent) as a yellow solid. m.p. 116 – 118 ; 1HNMR (CDCl3, 300 MHz) δ 7.15 (m, 2H), 6.89 (d, 1H, J = 7.7 Hz),6.88 (t, 1H, J = 7.7 Hz), 5.19 (dd,1H, J = 10.5, 7.0 Hz), 3.55 (dd, 1H, J = 15.8, 10.5 Hz), 3.37 (dd, 1H, J = 15.8, 7.0 Hz); FTIR (neat) 3391, 3049, 1047cm-1 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
87% | Stage #1: With 3-chloro-benzenecarboperoxoic acid In dichloromethane for 6 h; Inert atmosphere Stage #2: With methanol; potassium carbonate In dichloromethane at 20℃; for 14 h; Inert atmosphere |
A mixture of 2-allylphenol (5) (200 mg, 1.49 mmol), m-chloroperoxybenzoic acid (616 mg, 3.57 mmol) and dichloromethane (DCM, 30 mL) was stirred for 6 h. then K2CO3 (617 mg, 4.47 mmol) and methanol (25 mL) was added at room temperature. After stirring for 14 h, solvent was evaporated then water (15 mL) was added. The mixture was extracted with DCM (3× 20 mL). The combined extracts were washed with brine (10 mL), dried over anhydrous Na2SO4 and the solvent was evaporated.Purification via flash column chromatography (EtOAc/hexane = 1:7) provided (2,3-dihydrobenzofuran-2-yl)-methanol (6) (195 mg, 87percent) as a pale yellow oil. 1H NMR (CDCl3, 300 MHz) δ 7.17 (d, 1H, J = 7.4Hz), 7.11 (t, 1H, J = 7.6 Hz), 6.85(t, 1H, J = 7.4 Hz), 6.79 (d, 1H, J = 7.4 Hz), 4.91 (m, 1H), 3.85 (dd, 1H,J = 12.0, 3.2 Hz), 3.74 (dd, 1H, J = 12.0, 6.3 Hz), 3.25 (dd, 1H, J = 15.5, 9.4 Hz), 3.01 (dd, 1H, J = 15.5, 7.4 Hz); FTIR (neat) 3391, 3049, 1047 cm-1 |
28.4 mg | Stage #1: With 2,2,2-Trifluoroacetophenone; dihydrogen peroxide In acetonitrile; <i>tert</i>-butyl alcohol at 20℃; for 18 h; Green chemistry Stage #2: With 1,8-diazabicyclo[5.4.0]undec-7-ene In dichloromethane at 60℃; for 1 h; Green chemistry |
General procedure: The respective o-allylphenol 2 (0.40 mmol) was placed in a roundbottomed flask followed by consecutive addition of t-BuOH (0.4 mL), 2,2,2-trifluoro-1-phenylethanone (7.0 mg, 0.08 mmol), aqueous buffer solution (0.4 mL, 0.6 M K2CO3/4 × 10–4 M EDTA disodium salt), MeCN (0.64 mL, 6.40 mmol), and 30percent aq H2O2 (1.38 mL, 6.40 mmol).The reaction mixture was left stirring for 18 h. The crude product was dried (Na2SO4) and the solvent was removed in vacuo. The mixture was dissolved in CH2Cl2 (1.00 mL) followed by addition of DBU (54.0mg, 0.40 mmol). The mixture was stirred for 1 h at 60 °C and then purified by flash column chromatography (40–60percent EtOAc in PE) to afford the desired product 3. |
[ 56122-34-0 ]
1-(4-Hydroxyphenyl)-2-(2-methoxyphenoxy)propane-1,3-diol
Similarity: 0.89
[ 92409-15-9 ]
2-(2-Methoxyphenoxy)-1-(4-methoxyphenyl)propane-1,3-diol
Similarity: 0.89
[ 10535-17-8 ]
1-(3,4-Dimethoxyphenyl)-2-(2-methoxyphenoxy)propane-1,3-diol
Similarity: 0.88
[ 1083168-69-7 ]
(2,3-Dihydrobenzofuran-6-yl)methanol
Similarity: 0.84
[ 93885-41-7 ]
5-Methoxy-2,3-dihydrobenzofuran-2-carboxylic acid
Similarity: 0.80